CELEST Trademark

Trademark Overview


On Wednesday, October 11, 2023, a trademark application was filed for CELEST with the United States Patent and Trademark Office. The USPTO has given the CELEST trademark a serial number of 98219801. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 30, 2024. This trademark is owned by ReNAgade Therapeutics Management, Inc.. The CELEST trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment ...

Chemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, namey, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes

Research and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry
celest

General Information


Serial Number98219801
Word MarkCELEST
Filing DateWednesday, October 11, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds directed to lipid nanoparticles for the purpose of delivering pharmaceutical preparations to specific target tissue sites; drug delivery agents in the form of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acid molecules, enzymes, polypeptides, and compounds and agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations; drug delivery agents consisting of pharmaceutical preparations and therapeutic agents that facilitate the release and delivery of a wide variety of pharmaceutical preparations for RNA, gene therapy and mRNA regulation; drug delivery agents consisting of pharmaceutical and biological preparations for medical use that facilitate the release and delivery of a wide variety of pharmaceutical preparations for the treatment of genetic and genomic disorders by gene therapy and mRNA regulation for use in human and animal therapeutics; drug delivery agents consisting of pharmaceutical preparations that facilitate the release and delivery of a wide variety of pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders in humans and animals; pharmaceutical preparations for gene therapy and mRNA regulation; pharmaceutical preparations, namely, vaccines
Goods and ServicesChemical and biological agents for scientific and research use, namely, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, nucleic acids and modified nucleic acids, namey, short RNAs and messenger RNAs; nucleic acid sequences for scientific purposes, research purposes, and laboratory purposes other than medical and veterinary purposes
Goods and ServicesResearch and development in the field of technology and engineering, lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, drug delivery agents and RNAs for use in gene therapy and mRNA regulation; development of new technology for others for enabling the engineering and modification of lipids, lipid nanoparticles, lipid nanoparticle conjugates, lipid formulations, RNAs, namely, developing molecular and cellular biology reagents, techniques, drug delivery agents and assays for use in pharmaceutical and biomedical industry

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 16, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReNAgade Therapeutics Management, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events


Event DateEvent Description
Saturday, October 14, 2023NEW APPLICATION ENTERED
Monday, October 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 26, 2024ASSIGNED TO EXAMINER
Friday, May 17, 2024NON-FINAL ACTION E-MAILED
Monday, July 15, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, July 15, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, October 4, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 17, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 17, 2024NON-FINAL ACTION WRITTEN
Friday, October 4, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 4, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 4, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 30, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 30, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 4, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED